# Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)

> **NCT00306163** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 37 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Ciclesonide
- **DRUG:** Fluticasone

## Key facts

- **NCT ID:** NCT00306163
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2008-08
- **Final completion:** 2008-09
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2017-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00306163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00306163, "Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00306163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*